Skip to main content

Articles By Cassandra Calabrese, DO

Screen%20Shot%202018-10-24%20at%203.40.08%20PM.png

Checkpoint Inhibitor-related Myositis – Something Different

By Cassandra Calabrese, DO
24 October 2018

As expected, this year’s ACR meeting saw an upswing in the number of abstracts on immune related adverse events from checkpoint inhibitor therapy compared to last year.

Read Article
Liver.hepatitis.jpg

The Consequences and Cure of Hepatitis C

By Cassandra Calabrese, DO
26 March 2018

I spent this past week seeing hepatitis C patients with our hepatologists, and being a rheumatologist, I was looking forward to seeing extra-hepatic manifestations of HCV that we read about in text-books - cryoglobulinemic vasculitis, sicca syndrome, porphyria cutanea tarda and many others. I suppose I should not be surprised that the week passed without seeing a single one of these. 

Read Article
patient.safety.jpg

Prevention of HBV Infection: How Are We Doing?

By Cassandra Calabrese, DO
18 January 2018

In 2016 the WHO set out to eliminate HBV infection as a public health threat by 2030. So far, we are far from this goal as vaccine implementation has been suboptimal in a number of important patient populations, including patients with rheumatologic diseases, as well as other immunocompromising diseases like HIV.

Read Article
puzzle.Q_0.jpg

Q Fever - The Intersection of Rheum and ID

By Cassandra Calabrese, DO
02 October 2017

Read Article
vaccination.jpg

Why Rheumatologists Should Do Better Vaccinating this Flu Season

By Cassandra Calabrese, DO
12 September 2017

It is well known that influenza infection is more common in patients with rheumatologic diseases. Blumentals et al.

Read Article
vaccine.jpg

CDC: Pneumococcal Vaccination in Adults

By Cassandra Calabrese, DO
19 July 2017

Streptococcus pneumonia is a leading cause of morbidity and mortality in adults; including patients with autoimmune diseases who are at particular risk.

Read Article
infx.pneumonia.jpg

Lymphopenia and Steroids Increase the Risk of Pneumocystis Jiroveci in Systemic Rheumatic Diseases

By Cassandra Calabrese, DO
10 July 2017

It is well-known that patients with systemic autoimmune diseases are at risk for Pneumocystis jirovecii pneumonia (PJP) and although infrequent, it carries a high mortality. A new study shows lymphopenia and steroid use increases the risk of PJP.

Read Article
injection_1.jpg

Suspending Methotrexate for Influenza Vaccination

By Cassandra Calabrese, DO
12 June 2017

Vaccinating our rheumatoid arthritis patients against influenza every year is a safety priorty. However immunosuppressive therapies pose a challenge to vaccine administration as their use can hamper vaccine immunogenicity.

Read Article
ANCA.jpg

Venous Thromboembolism Risk Factors in ANCA-Associated Vasculitis

By Cassandra Calabrese, DO
03 May 2017

A retrospective analysis of four European vasculitis trials analyzes the risk venous thromboembolism (VTE) with ANCA-associated vasculitis and shows that CRP, cutaneous and GI involvement and baseline creatinine were most associated with VTE risk.

Read Article
mosquito.jpg

Rheumatic Manifestations Following Chikungunya Infection

By Cassandra Calabrese, DO
24 March 2017

In the Makonde language, “Chikungunya” translates to “that which bends up”, descriptive of the twisted posture of those infected secondary to intense joint and muscle pain experienced during the acute phase of the disease.  

Read Article
×